From

Applicant

Technology (CPC section)

CPC : C07K 14/7051 ×

Granted only Include patents without an Aachen institution as applicant

Reset

Patents 16 families

Sort: Newest Oldest Priority ⇩ CSV

Binding proteins and uses thereof
2026 NL2039954B1 granted Human necessities GBS Leiden

Mirjam, H.m. Heemskerk, J.h., Frederik Falkenburg

1

office
AGENTS FOR TREATING CELIAC DISEASE
2025 WO2025216635A1 Human necessities GBS Leiden

Mirjam H.M. Heemskerk, Sebastiaan Heidt, Frits Koning, Ilse Gille

1

office
HAEMATOPOIETIC-RESTRICTED MINOR HISTOCOMPATIBILITY ANTIGENS AND USES THEREOF
2025 WO2025159637A1 Chemistry & metallurgy GBS Leiden

Marieke Griffioen, J.H. Frederik Falkenburg

1

office
HAEMATOPOIETIC-RESTRICTED MINOR HISTOCOMPATIBILITY ANTIGENS AND USES THEREOF
2025 WO2025159638A1 Chemistry & metallurgy GBS Leiden

Marieke Griffioen, J.H. Frederik Falkenburg

1

office
TIMP3-DERIVED TEIPP NEOANTIGENS AND USES THEREOF
2024 WO2024219974A1 +2 publications Chemistry & metallurgy GBS Leiden

Sjoerd H. van der Burg, Thorbald van Hall, Koen A. Marijt, van der Berg, Sjoerd Henrikus, van Heil, Thorbald, Margett, Koen Abraham

3

offices
T CELL RECEPTORS DIRECTED AGAINST CANCER-ASSOCIATED ANTIGENS AND USES THEREOF
2024 WO2024101994A1 +1 publications Chemistry & metallurgy GBS Leiden

Mirjam H.M. Heemskerk, J.H. Frederik Falkenburg

2

offices
T CELL RECEPTORS DIRECTED AGAINST MELANOMA-ASSOCIATED ANTIGEN AND USES THEREOF
2023 EP4536703A1 +2 publications Chemistry & metallurgy GBS Leiden

Mirjam H.M. Heemskerk, J.H. Frederik Falkenburg

3

offices
TREATMENT OF HAEMATOLOGICAL MALIGNANCIES
2023 CA3250741A1 +1 publications Human necessities GBS Leiden

Marieke Griffioen, J.H. Frederik Falkenburg, J·h·弗雷德里克·福尔肯伯格, Griffioen, Mariko, Falkenberg, J H Frederik

2

offices
T CELL RECEPTORS DIRECTED AGAINST TRANSCRIPTION FACTOR WT1 AND USES THEREOF
2023 NL2031118B1 granted Chemistry & metallurgy GBS Leiden

Mirjam, H.m. Heemskerk, J.h., Frederik Falkenburg

1

office
T CELL RECEPTORS DIRECTED AGAINST JCHAIN AND USES THEREOF
2023 EP4479142A1 +2 publications Chemistry & metallurgy GBS Leiden

Mirjam H.M. Heemskerk, J.H. Frederik Falkenburg

3

offices
TREATMENT OF HAEMATOLOGICAL MALIGNANCIES
2022 US2022305102A1 Human necessities GBS Leiden

Marieke Griffioen, J.H. Frederik Falkenburg

1

office
T CELL RECEPTORS DIRECTED AGAINST BOB1 AND USES THEREOF
2022 CA3193694A1 +2 publications Human necessities GBS Leiden

Heemskerk, Mw Mirjam H. M., Falkenburg, de Heer J. H. Frederik, Mirjam H.M. Heemskerk, J.H. Frederik Falkenburg

3

offices
Receptores de células T dirigidos contra Bob1 y usos de los mismos
2022 ES2904301T3 Chemistry & metallurgy GBS Leiden

Mirjam H.M. Heemskerk, J.H. Frederik Falkenburg

1

office
TREATMENT OF HAEMATOLOGICAL MALIGNANCIES
2020 EP4327819A2 +3 publications Human necessities GBS Leiden

J·h·弗雷德里克·福尔肯伯格, Marieke Griffioen, J.H. Frederik Falkenburg, Marieke, Griffioen, J, H Frederik Falkenburg

3

offices
BINDING PROTEINS SPECIFIC FOR HA-1H AND USES THEREOF
2020 CA3115620A1 +1 publications Human necessities GBS Leiden

Mirjam H.M. Heemskerk, Frederik J.H. Falkenburg, J.H. Frederik Falkenburg

2

offices
T CELL RECEPTORS DIRECTED AGAINST THE PREFERENTIALLY EXPRESSED ANTIGEN OF MELANOMA AND USES THEREOF
2020 US2020054678A1 +2 publications Human necessities GBS Leiden

Mirjam H.M. Heemskerk, J.H. Frederik Falkenburg, Mirjam, H M Heemskerk, J, H Frederik Falkenburg

3

offices

16 results